Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L I Gordon

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Blood|November 24, 1999
A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensityL I Gordon, M Young, E Weller, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patientsP S Pegram, J P Phair, R McMahan, et al.
American Journal of Clinical Oncology|June 1, 1996
Management of early-stage Hodgkin's lymphoma. The radiation oncology experience at Northwestern University/Northwestern Memorial HospitalM A LaCombe, B B Mittal, L A Colangelo, et al.
Bone Marrow Transplantation|May 16, 2003
Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?M Y Ali, Y Oyama, J Monreal, et al.
Blood|November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomasJ N Winter, J Andersen, D Variakojis, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1982
Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survivalJ M Levett, H E Darakjian, T R DeMeester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiencyS H McDunn, J N Winter, D Variakojis, et al.
Bone Marrow Transplantation|July 22, 1999
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapyM B Kleinman, E L Wiley, M Guo, et al.
Cancer|March 5, 1998
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphomaL R Kong, C F Huang, D Hakimian, et al.
Blood|November 1, 1983
Estrogen receptor analysis in chronic lymphocytic leukemiaS T Rosen, Z Maciorowski, F Wittlin, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Blood|November 24, 1999
A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensityL I Gordon, M Young, E Weller, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patientsP S Pegram, J P Phair, R McMahan, et al.
American Journal of Clinical Oncology|June 1, 1996
Management of early-stage Hodgkin's lymphoma. The radiation oncology experience at Northwestern University/Northwestern Memorial HospitalM A LaCombe, B B Mittal, L A Colangelo, et al.
Bone Marrow Transplantation|May 16, 2003
Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?M Y Ali, Y Oyama, J Monreal, et al.
Blood|November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomasJ N Winter, J Andersen, D Variakojis, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1982
Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survivalJ M Levett, H E Darakjian, T R DeMeester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiencyS H McDunn, J N Winter, D Variakojis, et al.
Bone Marrow Transplantation|July 22, 1999
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapyM B Kleinman, E L Wiley, M Guo, et al.
Cancer|March 5, 1998
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphomaL R Kong, C F Huang, D Hakimian, et al.
Blood|November 1, 1983
Estrogen receptor analysis in chronic lymphocytic leukemiaS T Rosen, Z Maciorowski, F Wittlin, et al.
Pageof 8